Is Crohn's creeping fat an adipose tissue?

Background: In human pathology, the “creeping fat” (CF) of the mesentery is unique to Crohn's disease (CD). CF is usually referred to as an ectopic extension of mesenteric adipose tissue (MAT). However, since no animal model developing CF has ever been established, very little is known about this type of fat‐depot expansion and its role in the development of the disease. Methods: We developed and standardized an experimental protocol in mice that reproducibly induces CF development when a severe colonic inflammation is obtained by intracolonic instillation of DNBS. Results: Macro‐microscopic observations revealed a fatty appearance of CF. Yet when compared to MAT from the same animals, CF contains very little triglycerides, few adipocytes, and we observed a very low expression and protein levels of both adipose markers (hormone‐sensitive lipase, perilipin) and adipocytokines (leptin, adiponectin). The decreased expression of perilipin in CF was also observed by immunohistochemistry. Conversely, the expression of proinflammatory and fibrous markers (Pref‐1) was much higher in CF than in MAT. These observations were fully consistent with those made on CF recovered from five CD patients and compared with subcutaneous and mesenteric fat from the same patients. Conclusions: Altogether, this work reports an original experimental mice model of CF. In this model we establish for the first time that CF only occurs in severe colonic inflammation and shows an inflammatory, fibrous but not an adipose pattern. (Inflamm Bowel Dis 2011)

[1]  R. Shamir Nutritional Aspects in Inflammatory Bowel Disease , 2009, Journal of pediatric gastroenterology and nutrition.

[2]  U. Schweizer,et al.  Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. , 2009, Nutrition.

[3]  N. Van Rooijen,et al.  Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis , 2007, The Journal of experimental medicine.

[4]  C. Auffray,et al.  HNF1α Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation* , 2007, Journal of Biological Chemistry.

[5]  Stefan Wirtz,et al.  Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.

[6]  G. Fantuzzi,et al.  Adiponectin deficiency protects mice from chemically induced colonic inflammation. , 2007, Gastroenterology.

[7]  M. Matsuda,et al.  Effect of adiponectin on murine colitis induced by dextran sulfate sodium. , 2006, Gastroenterology.

[8]  C. Pothoulakis,et al.  Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Kouroumalis,et al.  Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[10]  P. Sharma,et al.  Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett’s—what is the interplay? , 2005, Gut.

[11]  S. Kihara,et al.  Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s disease , 2005, Gut.

[12]  J. Suttles,et al.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.

[13]  J. Galmiche,et al.  Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. , 2003, Gastroenterologie clinique et biologique.

[14]  C. Pond,et al.  The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats , 2003, Journal of anatomy.

[15]  R. Paschke,et al.  Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. , 2003, Biochemical and biophysical research communications.

[16]  P. Arner,et al.  Regional differences in protein production by human adipose tissue. , 2001, Biochemical Society transactions.

[17]  C. Smas,et al.  Function of pref-1 as an inhibitor of adipocyte differentiation , 2000, International Journal of Obesity.

[18]  G. Oppenheimer,et al.  Regional ileitis: a pathologic and clinical entity. 1932. , 2000, The Mount Sinai journal of medicine, New York.

[19]  D. Jewell,et al.  The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link , 2000, The Journal of pathology.

[20]  J. Auwerx,et al.  Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. , 1999, Gastroenterology.

[21]  N. Shepherd,et al.  Fat‐wrapping in Crohn's disease: Pathological basis and relevance to surgical practice , 1992, The British journal of surgery.

[22]  J. Wallace,et al.  Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. , 1992, Gastroenterology.

[23]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[24]  G. Oppenheimer,et al.  Regional ileitis; a pathologic and clinical entity. , 1952, The American journal of medicine.

[25]  REGIONAL ILEITISA PATHOLOGIC AND CLINICAL ENTITY , 2008 .